Last reviewed · How we verify
tirofiban intracoronary bolus-only
tirofiban intracoronary bolus-only is a glycoprotein IIb/IIIa inhibitor Small molecule drug developed by Kosuyolu Heart Hospital. It is currently in Phase 3 development for Acute coronary syndrome, Unstable angina. Also known as: Aggrastat.
Tirofiban is a non-peptide antagonist of the glycoprotein IIb/IIIa receptor, inhibiting platelet aggregation.
Tirofiban is a non-peptide antagonist of the glycoprotein IIb/IIIa receptor, inhibiting platelet aggregation. Used for Acute coronary syndrome, Unstable angina.
At a glance
| Generic name | tirofiban intracoronary bolus-only |
|---|---|
| Also known as | Aggrastat |
| Sponsor | Kosuyolu Heart Hospital |
| Drug class | glycoprotein IIb/IIIa inhibitor |
| Target | glycoprotein IIb/IIIa receptor |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
By binding to the glycoprotein IIb/IIIa receptor, tirofiban prevents the final common pathway of platelet aggregation, thereby reducing the risk of thrombotic complications in patients undergoing coronary interventions.
Approved indications
- Acute coronary syndrome
- Unstable angina
Common side effects
- Bleeding
- Thrombocytopenia
- Anemia
Key clinical trials
- Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tirofiban intracoronary bolus-only CI brief — competitive landscape report
- tirofiban intracoronary bolus-only updates RSS · CI watch RSS
- Kosuyolu Heart Hospital portfolio CI
Frequently asked questions about tirofiban intracoronary bolus-only
What is tirofiban intracoronary bolus-only?
How does tirofiban intracoronary bolus-only work?
What is tirofiban intracoronary bolus-only used for?
Who makes tirofiban intracoronary bolus-only?
Is tirofiban intracoronary bolus-only also known as anything else?
What drug class is tirofiban intracoronary bolus-only in?
What development phase is tirofiban intracoronary bolus-only in?
What are the side effects of tirofiban intracoronary bolus-only?
What does tirofiban intracoronary bolus-only target?
Related
- Drug class: All glycoprotein IIb/IIIa inhibitor drugs
- Target: All drugs targeting glycoprotein IIb/IIIa receptor
- Manufacturer: Kosuyolu Heart Hospital — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Acute coronary syndrome
- Indication: Drugs for Unstable angina
- Also known as: Aggrastat
- Compare: tirofiban intracoronary bolus-only vs similar drugs
- Pricing: tirofiban intracoronary bolus-only cost, discount & access